Quantitative Ex Vivo Imaging of 225Ac with the iQID Alpha Camera

被引:0
|
作者
Miller, C. [1 ,2 ]
Rousseau, J. [3 ]
Crawford, J. [4 ]
Miller, B. [5 ,6 ]
Benard, F. [3 ,7 ,8 ]
Rahmim, A. [1 ,2 ,8 ]
Uribe, C. [7 ,8 ]
机构
[1] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada
[2] BC Canc Res Inst, Dept Integrat Oncol, Vancouver, BC, Canada
[3] BC Canc Res Inst, Dept Mol Oncol, Vancouver, BC, Canada
[4] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada
[5] Univ Colorado Sch Med, Dept Radiat Oncol, Aurora, CO USA
[6] Univ Arizona, Coll Opt Sci, Tucson, AZ USA
[7] BC Canc, PET Funct Imaging, Vancouver, BC, Canada
[8] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-0044
引用
收藏
页码:S21 / S22
页数:2
相关论文
共 50 条
  • [41] Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC
    Hooijman, Eline L.
    Chalashkan, Yozlem
    Ling, Sui Wai
    Kahyargil, Figen F.
    Segbers, Marcel
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Seimbille, Yann
    Koolen, Stijn L. W.
    Brabander, Tessa
    de Blois, Erik
    PHARMACEUTICS, 2021, 13 (05)
  • [42] 225Ac Prostate-Specific Membrane Antigen Posttherapy α Imaging Comparing 2 and 3 Photopeaks
    Usmani, Sharjeel
    Rasheed, Rashid
    Al kandari, Fareeda
    Marafi, Fahad
    Naqvi, Syed Ali Raza
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) : 401 - 403
  • [43] Optimizing 225Ac SPECT acquisition times by using a sparse view imaging protocol: a feasibility study
    Liubchenko, G.
    Boening, G.
    Zacherl, M.
    Rumiantcev, M.
    Sheikh, G. T.
    Unterrainer, L.
    Gildehaus, F.
    Brendel, M.
    Resch, S.
    Ziegler, S.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S163 - S163
  • [44] Treatment of prostate cancer xenografts with the targeted alpha-particle nanogenerator [225Ac]Ac-DOTA-YS5
    Bidkar, Anil
    Wang, Sinan
    Bobba, Kondapa
    Bidlingmaier, Scott
    Su, Yang
    Egusa, Emily
    Tang, Ryan
    Chou, Jonathan
    Aggarwal, Rahul
    He, Jiang
    Seo, Youngho
    Liu, Bin
    Flavell, Robert
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S31 - S31
  • [45] Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac
    Bailey, Tyler A.
    Wacker, Jennifer N.
    An, Dahlia D.
    Carter, Korey P.
    Davis, Ryan C.
    Mocko, Veronika
    Larrabee, John
    Shield, Katherine M.
    Lam, Mila Nhu
    Booth, Corwin H.
    Abergel, Rebecca J.
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 110 : 28 - 36
  • [46] Production experiments for 225Ac using an electron linear accelerator and radiolabeling tests using the produced alpha emitter
    Maeda, M.
    Tadokoro, T.
    Ueno, Y.
    Nishida, K.
    Kani, Y.
    Sasaki, T.
    Watanabe, T.
    Kikunaga, H.
    Kashiwagi, S.
    Shirasaki, K.
    Sekimoto, S.
    Ohtsuki, T.
    Inagaki, M.
    Fukutani, S.
    Shibahara, Y.
    Fujii, H.
    Yoshimoto, M.
    Ohnuki, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S33 - S34
  • [47] Survival impact of [225Ac]Ac-DOTATOC alpha-therapy in a preclinical model of pancreatic neuroendocrine tumor liver micrometastases
    Lugat, Alexandre
    Chouin, Nicolas
    Chocteau, Florian
    Esnault, Mathilde
    Marionneau-Lambot, Severine
    Gouard, Sebastien
    Frampas, Eric
    Faivre-Chauvet, Alain
    Bourgeois, Mickael
    Morgenstern, Alfred
    Bruchertseifer, Frank
    Cherel, Michel
    Kraeber-Bodere, Francoise
    Ansquer, Catherine
    Gaschet, Joelle
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (02) : 730 - 743
  • [48] Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model
    Liu Dijie
    Li, Mengshi
    Dai, Zhiming
    Cagle, Brianna
    Lee, Dongyoul
    Schultz, Michael
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S265 - S266
  • [49] Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy
    Leszek Królicki
    Frank Bruchertseifer
    Jolanta Kunikowska
    Henryk Koziara
    Dariusz Pawlak
    Radosław Kuliński
    Rafał Rola
    Adrian Merlo
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3595 - 3605
  • [50] Dose escalation study of targeted alpha therapy with [225Ac]Ac-DOTA-substance P in recurrence glioblastoma - safety and efficacy
    Krolicki, Leszek
    Bruchertseifer, Frank
    Kunikowska, Jolanta
    Koziara, Henryk
    Pawlak, Dariusz
    Kulinski, Radoslaw
    Rola, Rafal
    Merlo, Adrian
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (11) : 3595 - 3605